TY - JOUR
T1 - Inclusion of methotrexate in alkyl-cyclodextrins: effects of host substituents on the stability of complexes
AU - PATTARINO, Franco
AU - GIOVANNELLI, Lorella
AU - GIOVENZANA, Giovanni Battista
AU - RINALDI, Maurizio
AU - TROTTA, M.
PY - 2005/1/1
Y1 - 2005/1/1
N2 - The formation of complexes between an antineoplastic drug, methotrexate (MTX), and a series of native cyclodextrins (αCD, βCD, γCD) and synthetic or commercial β-derivatives (methylated, dimethylated and hydroxypropylated βCDs) was studied using the phase solubility and permeation methods, NMR and DSC. The apparent stability constants determined from the solubility diagram (Kcs) are in excellent agreement (P < 0.00001) with those calculated by the permeation method (Kcp). The degree of substitution (DS) and position of substituents on glucose re- sidues significantly affect the complexing ability of β-inclusion agents. In particular, for dimethyl-derivatives, the presence of the alkyl-groups at the secondary face of CD (positions 2 and 3), sterically prevents host-guest interactions, while a methyl group in position 6 allows an easier association with MTX
AB - The formation of complexes between an antineoplastic drug, methotrexate (MTX), and a series of native cyclodextrins (αCD, βCD, γCD) and synthetic or commercial β-derivatives (methylated, dimethylated and hydroxypropylated βCDs) was studied using the phase solubility and permeation methods, NMR and DSC. The apparent stability constants determined from the solubility diagram (Kcs) are in excellent agreement (P < 0.00001) with those calculated by the permeation method (Kcp). The degree of substitution (DS) and position of substituents on glucose re- sidues significantly affect the complexing ability of β-inclusion agents. In particular, for dimethyl-derivatives, the presence of the alkyl-groups at the secondary face of CD (positions 2 and 3), sterically prevents host-guest interactions, while a methyl group in position 6 allows an easier association with MTX
UR - https://iris.uniupo.it/handle/11579/30412
M3 - Article
SN - 1773-2247
VL - 15
SP - 465
EP - 468
JO - Journal of Drug Delivery Science and Technology
JF - Journal of Drug Delivery Science and Technology
IS - 6
ER -